NICE guidelines (NG136, NG28) recommend individualised blood pressure targets, typically below 140/90 mmHg for most people with diabetes, or below 130/80 mmHg if you have kidney, eye, or cerebrovascular disease
Unlike single-target GLP-1 receptor agonists such as semaglutide, retatrutide is being studied for its capacity to activate three distinct metabolic hormone receptor pathways through a single molecule, a design that places it in a separate category from both mono- and dual-agonist compounds currently in clinical use
That pressure is what causes the classic symptoms: localized pain, radiating pain down a leg (sciatica) or arm, numbness, tingling, and muscle weakness
That means you should interpret results cautiously effect sizes in rodent cognition studies often don't translate 1:1 to humans
Bifidobacterium breve intervention combined with environmental enrichment alleviates cognitive impairment by regulating the gut microbiota and microbial metabolites in Alzheimers disease mice
Why It Matters for Patients Targeting stubborn fat: Belly fat and liver fat are among the most harmful types of fat for long-term health